Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Ubidecarenone 30mg / Magnesium oxide 150mg tablets |
| BNF code | 091102000AABTBT |
| Virtual Therapeutic Moiety | Ubidecarenone + Magnesium oxide |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 16 Feb 2017 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Magnesium oxide |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 150.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Ubidecarenone |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 30.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Ubidecarenone 30mg / Magnesium oxide 150mg tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_1.2.0_20250113000001, imported on 14th January 2025 at 04:06:47.